RaphaS Co., Ltd. (214260)

Overview

Raphas Co., Ltd., established in 2006, is an innovator in the field of skin-based drug delivery systems, with a strong presence across South Korea, Japan, and China. The company specializes in leveraging cutting-edge technology to offer alternative solutions for topical drug delivery and cosmetic applications. With its headquarters situated in Seoul, South Korea, Raphas Co., Ltd. is at the forefront of developing and delivering products designed to enhance the effectiveness and user experience of skin treatments and cosmetics, contributing to their growing prominence in the international market.

Products and Services

• Cosmetics under the Acropass Brand:

Raphas Co., Ltd. has developed a proprietary range of cosmetics under its Acropass brand, focusing on creating innovative products that cater to various skin care needs. These include advanced solutions for targeted concerns such as wrinkle reduction, freckle lightening, and acne treatment. Each product is designed using the company’s specialized skin-based drug delivery technology to enhance penetration and effectiveness.

• Original Design Manufacturer (ODM) Services:

The company offers comprehensive ODM services to clients looking to develop customized cosmetic products. This service covers the entire product development process, from initial concept to final production, ensuring that each product meets the specific requirements and quality standards of the client. Raphas Co., Ltd.’s ODM services are tailored to produce a wide range of cosmetics aimed at tackling common skin issues such as wrinkles, freckles, and acne, leveraging their proprietary technology and in-depth industry knowledge.

• Medical Contract Manufacturing Services:

Beyond cosmetics, Raphas Co., Ltd. extends its technological expertise to the medical field by providing contract manufacturing services. This includes the development and manufacturing of medical devices and products that utilize the company’s innovative skin-based drug delivery systems. These services are aimed at pharmaceutical companies and medical institutions looking for advanced solutions in transdermal drug delivery and other topical applications, thus bridging the gap between cosmetics and medical treatments.